Artificial Cells, Blood Substitutes, And Biotechnology

*Artificial Cells, Blood Substitutes, and Biotechnology*
\|Subject \|Discipline}}	Biochemistry/Biotechnology
Language	English
Edited by	Thomas M.S. Chang
Publication details
History	1973–present
Publisher	Informa Healthcare (UK)
Frequency	8/year
Open access	no
Standard abbreviations;
ISO 4	Artif. Cells Blood Substit. Biotechnol.
Indexing
ISSN	1532-4184 (print); 1073-1199 (web);
Links
	Journal homepage;

Artificial Cells, Blood Substitutes, and Biotechnology is an academic journal that publishes review articles on the development of artificial cells, tissue engineering, artificial organs, blood substitutes, cell therapy, gene and drug delivery systems, bioencapsulation nanosensors, nanodevices and other areas of biotechnology. It is published by Informa Healthcare.

Core areas

Tissues and organs
Artificial cells
Molecules
Blood substitutes
Tissue engineering
Stem cells
Gene therapy
Drug delivery

Editor-in-Chief

Thomas M.S. Chang, O.C., M.D., C.M., Ph.D., FRCP(C), FRS(C) is the Editor-in-Chief of Artificial Cells,

Blood Substitutes, and Biotechnology.^[1]

Publication format

Artificial Cells, Blood Substitutes, and Biotechnology publishes 8 issues per year in simultaneous print and online editions.

References

↑ "Editorial Board Members". informhealthcare.com. http://www.informahealthcare.com/page/EditorialAdvisoryBoard?journalCode=abb. Retrieved 2009-09-16.

External links

Artificial Cells, Blood Substitutes, and Biotechnology homepage of Artificial Cells Blood Substitutes and Biotechnology

0.00

(0 votes)

[1] "Editorial Board Members". informhealthcare.com. http://www.informahealthcare.com/page/EditorialAdvisoryBoard?journalCode=abb. Retrieved 2009-09-16.